AstraZeneca

FlyPharma Europe unites pharma, biotech and bio pharma with air cargo logistics

IDT Biologika, a global contract manufacturer of vaccines and active ingredients based in Dessau, also in Saxony-Anhalt, partnered with AstraZeneca and Johnson &Johnson to fill millions of vials with their

WHO recommends Valneva’s COVID-19 vaccine for those aged between 18 to 50 years old

as people who received the Oxford/AstraZeneca recombinant COVID-19 vaccine – ChAdOx1-S – following two doses of the vaccine.

AstraZeneca and Merck’s Lynparza combination therapy receives FDA priority review in first-line prostate cancer

AstraZeneca (AZ) and Merck’s – known as MSD outside the US and Canada – Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone has been granted Priority Review by the US

AstraZeneca and Daiichi Sankyo’s Enhertu shows significant improvement for breast cancer patients

AstraZeneca (AZ) and Daiichi Sankyo have shared positive results from a phase 3 trial on the use of Enhertu (trastuzumab deruxtecan) in the treatment of patients with HER2-positive metastatic breast

Lack of evidence for AstraZeneca’s COVID-19 vaccine says UK Department of Health

The UK’s Department of Health and Social Care has decided not to buy AstraZeneca’s COVID-19 drug, Evusheld, due to a lack of evidence about the vaccine’s effectiveness ... Developed by AstraZeneca, Evusheld is a combination of two antibodies that

[ Previous 5 results ] 12 13 14 15 16 17 18 19 20 21 [ Next 5 results ]